Less aggressive treatment better for heart patients who go into shock

August 24, 2020

New Haven, Conn. -- Less is sometimes more when treating heart patients who go into shock after a heart attack.

A new study found that more than 30 percent of hospital patients who have a heart attack complicated by low blood pressure undergo an aggressive treatment in which coronary stents are placed in cardiac blood vessels showing any restriction of blood flow to the heart. This is happening despite the existence of a less aggressive approach, called a "culprit-only" strategy, that places stents only in the blocked blood vessels that caused the heart attack.

The study, led by Yale and Beth Israel Deaconess Medical Center, looked at patients undergoing either of the two procedures at hospitals in the United States from 2009 to 2018. The study's aim was to evaluate patterns in the use of the aggressive, multivessel procedure.

In 2017, an unrelated study found that the more aggressive procedure may lead to a higher death rate than the more conservative treatment. But until now, no research has examined patterns in the use of the two treatments such as relative frequency and its variation among hospitals.

"Our work emphasizes the need for optimization of care practices for a group of patients who experience really bad outcomes," said Dr. Rohan Khera, an assistant professor of cardiovascular medicine at Yale and first author of the study. "In this case, less is more."

The senior author of the study is Dr. Robert Yeh of Beth Israel Deaconess Medical Center.

Overall, more than one-third of all heart attack patients who go into shock die during their initial hospital presentation. About half of them die within one year. By contrast, the mortality rate for heart attack patients who do not go into shock is less than 5%.

Despite concerns about the aggressive stenting of multiple blood vessels raised in the 2017 research, Khera said, his team found no early signals that its revelations have affected the proportion of patients undergoing aggressive versus more conservative stenting approaches.

But, he said, the team found wide variation among hospitals as to the approach they use -- and that "those hospitals using multi-vessel treatments more frequently had worse patient outcomes."
-end-
The new study appears in the journal JAMA Internal Medicine.

Co-authors from Yale were Yongfei Wang, Nihar Desai, Harlan Krumholz, and Jeptha Curtis.

The American College of Cardiology funded the research.

Yale University

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.